MITBurn®
Referências:
C. Thomas, A. Gioiello, L. Noriega et al., “TGR5-mediated bile acid sensing controls glucose homeostasis,” Cell Metabolism, vol.
10, no. 3, pp. 167–177, 2009
De Melo, C. L., Queiroz, M. G. R., Fonseca, S. G. C., Bizerra, A. M. C., Lemos, T. L. G., Melo, T. S., … Rao, V. S. (2010). Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet.
Chemico-Biological Interactions, 185(1), 59–65. doi:10.1016/j.cbi.2010.02.028
Guo, C., Chen, W.-D., & Wang, Y.-D. (2016). TGR5, Not Only a Metabolic Regulator. Frontiers in Physiology, 7. doi:10.3389/fphys. 2016.00646
Guo, C., Xie, S., Chi, Z., Zhang, J., Liu, Y., Zhang, L., … Wang, D. (2016). Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. Immunity, 45(4), 802–816. doi:10.1016/j.immuni.2016.09.008
H. Sato, C. Genet, A. Strehle et al., “Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea,” Biochemical and Biophysical Research Communications, vol. 362, no. 4, pp. 793–798, 2007.
Jafri, L., Saleem, S., Calderwood, D., Gillespie, A., Mirza, B., & Green, B. D. (2016). Naturally-occurring TGR5 agonists modulating glucagon-like peptide-1 biosynthesis and secretion. Peptides, 78, 51–58. doi:10.1016/j.peptides.2016.01.015
Maruyama,T.,Miyamoto,Y.,Nakamura,T.,Tamai,Y.,Okada,H., Sugiyama,E.,etal.(2002).Identificationofmembrane-typereceptor forbileacids(M-BAR). Biochem.Biophys.Res.Commun. 298,714–719. doi:10.1016/S0006-291X(02)02550-0
de Melo C.L., Queiroz, M.G.R., Fonseca, S.G.C. , Bizerra, A.M.C., Lemos, T.L.G., Melo, T.S., Santos, F.A, Rao, V.S. Oleanolic acid, a natural triterpenoid improves blood glucose tolerance in normal mice and ameliorates visceral obesity in mice fed a high-fat diet, Chem. Biol. Interact. 185 (2010) 59e65, https:// doi.org/10.1016/j.cbi.2010.02.028
Pols, T., Eggink, H., & Soeters, M. (2014). TGR5 ligands as potential therapeutics in inflammatory diseases. International Journal
of Interferon, Cytokine and Mediator Research, 27. doi:10.2147/ijicmr.s40102
R. Martín, J. Carvalho-Tavares, M. Hernandez, M. Arn ´ es, ´ V. Ruiz-Gutierrez, and M. L. Nieto, “Beneficial actions of ´ oleanolic
acid in an experimental model of multiple sclerosis: a potential therapeutic role,” Biochemical Pharmacology, vol. 79, no. 2, pp.
198–208, 2010
S. Fiorucci, S. Cipriani, F. Baldelli, and A. Mencarelli, “Bile acid-activated receptors in the treatment of dyslipidemia and related
disorders,” Progress in Lipid Research, vol. 49, no. 2, pp. 171–185, 2010
Sato, Hiroyuki & Genet, Cédric & Strehle, Axelle & Thomas, Charles & Lobstein, Annelise & Wagner, Alain & Mioskowski, Charles
& Auwerx, Johan & Saladin, Régis. (2007). Anti-hyperglycemic activity of a TGR5 agonist isolated from Olea europaea. Biochemical
and biophysical research communications. 362. 793-8. 10.1016/j.bbrc.2007.06.130.
Strehle, Axelle. “Characterisation of triterpenoids as TGR5 agonists and their effects on metabolism.” (2009).
Teodoro, J. S., Rolo, A. P., Carvalho, R. A., & Palmeira, C. M. (2018). Exploring the role of the bile acid receptor TGR5 in bile acid
mediated obesity control: New insights from a CRISPR/Cas9 adipocyte model. Free Radical Biology and Medicine, 120, S141.
doi:10.1016/j.freeradbiomed.2018.04.466
Velazquez-Villegas, L., Perino, A., Lemos, V. et al. TGR5 signalling promotes mitochondrial fission and beige remodelling of white
adipose tissue. Nat Commun 9, 245 (2018). https://doi.org/10.1038/s41467-017-02068-0
Wang, X., Liu, R., Zhang, W., Zhang, X., Liao, N., Wang, Z., … Hai, C. (2013). Oleanolic acid improves hepatic insulin resistance via
antioxidant, hypolipidemic and anti-inflammatory effects. Molecular and Cellular Endocrinology, 376(1-2), 70–80. doi:10.1016/
